GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.53M | -14.93M | -16.45M | -15.64M | -15.15M |
| Total Depreciation and Amortization | 529.90K | 618.40K | 714.20K | 925.00K | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.63M | 1.12M | 616.60K | -160.40K | -937.50K |
| Change in Net Operating Assets | 853.50K | 3.60M | 6.37M | 3.57M | 946.50K |
| Cash from Operations | -10.52M | -9.59M | -8.74M | -11.30M | -13.99M |
| Capital Expenditure | -4.60K | -2.30K | 0.00 | -500.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 218.40K | 83.20K | -52.60K | -15.50K | 19.50K |
| Cash from Investing | 213.80K | 80.90K | -52.60K | -16.00K | 18.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.25M | -2.05M | -2.84M | -2.87M | -2.90M |
| Issuance of Common Stock | 6.18M | 5.96M | 5.74M | 10.78M | 15.81M |
| Repurchase of Common Stock | -- | -2.50K | -5.00K | -16.00K | -27.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.02M | 1.42M | -1.18M | -263.50K | 651.00K |
| Cash from Financing | 10.40M | 6.13M | 1.86M | 8.22M | 14.64M |
| Foreign Exchange rate Adjustments | 5.20K | -151.40K | -312.90K | -315.20K | -317.20K |
| Miscellaneous Cash Flow Adjustments | 100.00 | 0.00 | 0.00 | 600.00 | 1.10K |
| Net Change in Cash | 104.20K | -3.53M | -7.25M | -3.41M | 349.10K |